Smith & Nephew H1 Results Climb, Backs FY25 Outlook; Plans $500 Mln Buyback

Smith & Nephew Plc reported robust first-half 2025 results, with profit before tax rising to $362 million and revenue increasing 4.7% to $2.96 billion, driven by 5% underlying growth. The medical equipment maker reaffirmed its fiscal 2025 outlook, projecting 5.5% reported revenue growth and an expanded trading profit margin of 19-20%. Concurrently, the company announced a 4.2% increase in its interim dividend to 15.0 cents per share and an additional $500 million share buyback program for the second half of 2025, signaling strong operational performance and a commitment to enhanced shareholder returns.

Analysis

Smith & Nephew Plc (SNN) reported a robust first half for fiscal 2025, demonstrating significant bottom-line growth and top-line acceleration. Profit before taxation increased from $253 million to $362 million year-over-year, driving a 36.6% surge in earnings per share to 33.5 cents. Revenue grew 4.7% to $2.96 billion, supported by a 5.0% underlying increase, with second-quarter performance indicating accelerating momentum as underlying revenue growth reached 6.7%. Management reaffirmed its full-year 2025 guidance, projecting 5.0% underlying revenue growth and an expansion of its trading profit margin to a range of 19.0% to 20.0%. This outlook is maintained despite an anticipated net negative impact of $15 to $20 million from tariffs, signaling strong confidence in operational efficiency. The company's positive outlook is further underscored by its commitment to shareholder returns, evidenced by a 4.2% increase in the interim dividend and the announcement of an additional $500 million share buyback program for the second half of the year.

Key Decisions for Investors

• Given the strong earnings, accelerated Q2 revenue growth, and enhanced capital return program, investors could view this report as a strong validation of the company's operational execution and financial health.
• It is crucial to monitor the company's ability to achieve its guided trading profit margin expansion to 19.0-20.0%, as this will be a key test of its capacity to manage costs and the stated tariff impacts effectively.
• The reaffirmed full-year guidance, coupled with the new $500 million share buyback, may warrant a re-evaluation of existing positions for a potential increase in exposure, contingent on broader market and sector conditions.